NASDAQ:CELC

Celcuity Stock Insider Trading

Healthcare > Biotechnology

Buy CELC

*Your capital is at risk

$86.38

-1.26 (-1.44%)

At Close: Jul 31, 2026

Celcuity Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -83.68. In total, the insiders bought 14.24M and sold 3.68M CELC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-83.68
● Buy	14.24M shares
● Sell	3.68M shares
56% Buy Activity Moderate Negative Correlation
Sell Signal High Confidence Jul 14, 2026 Analysis Breakdown: Strongly supported by a very low Insider Power Score of -83.68. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 11, 2025 Buy	Common Stock X-InTheMoney	Nigon Richard Director	Director	4 672 Value: $35.3K
Sep 11, 2025 Sell	Warrants (right to buy) X-InTheMoney	Nigon Richard Director	Director	3 245 Value: $24.5K
Sep 11, 2025 Sell	Warrants (right to buy) X-InTheMoney	Nigon Richard Director	Director	3 245 Value: $24.5K
Sep 11, 2025 Buy	Common Stock X-InTheMoney	Nigon Richard Director	Director	4 672 Value: $35.3K
Sep 11, 2025 Buy	Common Stock X-InTheMoney	Nigon Richard Director	Director	3 245 Value: $24.5K
Sep 08, 2025 Buy	Common Stock P-Purchase	Baker Bros. Advisors Lp 10 Percent Owner	10% Owner	4 212 Value: $244.4K
Sep 08, 2025 Buy	Common Stock P-Purchase	Baker Bros. Advisors Lp 10 Percent Owner	10% Owner	151 524 Value: $8.52M
Sep 08, 2025 Buy	Common Stock P-Purchase	Baker Bros. Advisors Lp 10 Percent Owner	10% Owner	388 Value: $22.5K
Sep 08, 2025 Buy	Common Stock P-Purchase	Baker Bros. Advisors Lp 10 Percent Owner	10% Owner	13 976 Value: $785.7K
Sep 08, 2025 Buy	Common Stock P-Purchase	Baker Bros. Advisors Lp 10 Percent Owner	10% Owner	13 976 Value: $785.7K
Sep 08, 2025 Buy	Common Stock P-Purchase	Baker Bros. Advisors Lp 10 Percent Owner	10% Owner	388 Value: $22.5K
Sep 08, 2025 Buy	Common Stock P-Purchase	Baker Bros. Advisors Lp 10 Percent Owner	10% Owner	151 524 Value: $8.52M
Sep 08, 2025 Buy	Common Stock P-Purchase	Baker Bros. Advisors Lp 10 Percent Owner	10% Owner	4 212 Value: $244.4K
Sep 02, 2025 Buy	Common Stock X-InTheMoney	Sullivan Brian F. Chief Executive Officer	CEO / President	104 340 Value: $839.9K
Sep 02, 2025 Sell	Warrants (right to buy) X-InTheMoney	Sullivan Brian F. Chief Executive Officer	CEO / President	104 340 Value: $839.9K
Sep 02, 2025 Sell	Warrants (right to buy) X-InTheMoney	Sullivan Brian F. Chief Executive Officer	CEO / President	104 340 Value: $839.9K
Sep 02, 2025 Buy	Common Stock X-InTheMoney	Sullivan Brian F. Chief Executive Officer	CEO / President	104 340 Value: $839.9K
Aug 18, 2025 Buy	Stock Option (right to buy) A-Award	Hahne Vicky Chief Financial Officer	C-Suite Officer	80 000 Value: $4.13M
Aug 18, 2025 Buy	Stock Option (right to buy) A-Award	Laing Lance G. Chief Science Officer	Officer	100 000 Value: $5.16M
Aug 18, 2025 Buy	Stock Option (right to buy) A-Award	Sullivan Brian F. Chief Executive Officer	CEO / President	250 000 Value: $12.9M
Aug 18, 2025 Buy	Stock Option (right to buy) A-Award	Sullivan Brian F. Chief Executive Officer	CEO / President	150 000 Value: $7.74M
Aug 18, 2025 Buy	Stock Option (right to buy) A-Award	Sullivan Brian F. Chief Executive Officer	CEO / President	150 000 Value: $7.74M
Aug 18, 2025 Buy	Stock Option (right to buy) A-Award	Sullivan Brian F. Chief Executive Officer	CEO / President	250 000 Value: $12.9M
Aug 18, 2025 Buy	Stock Option (right to buy) A-Award	Laing Lance G. Chief Science Officer	Officer	100 000 Value: $5.16M
Aug 18, 2025 Buy	Stock Option (right to buy) A-Award	Hahne Vicky Chief Financial Officer	C-Suite Officer	80 000 Value: $4.13M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CELCUITY INC

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I...

Read Full Profile Here